To generate progress in the direction of precision therapeutics, we must significantly improve our understanding of condition. Researchers globally are exploring the mobile and molecular basis of condition, gathering a range of multimodal datasets that may result in electronic and Organic biomarkers for diagnosis, severity and progression. Two impo